<?xml version="1.0" ?>
<document id="9dd88265053594d2736a884a8b972b6ae94218c5">
  <chunk id="9dd88265053594d2736a884a8b972b6ae94218c5.c0" text="CD8+ T Cells Responding to the Middle East Respiratory Syndrome Coronavirus Nucleocapsid Protein Delivered by Vaccinia Virus MVA in Mice">
    <entity charOffset="76-88" id="9dd88265053594d2736a884a8b972b6ae94218c5.c0.e0" ontology_id="GO_0019013" text="Nucleocapsid" type="gene_function"/>
  </chunk>
  <chunk id="9dd88265053594d2736a884a8b972b6ae94218c5.c1" text="Middle East respiratory syndrome coronavirus (MERS-CoV), a novel infectious agent causing severe respiratory disease and death in humans, was first described in 2012. Antibodies directed against the MERS-CoV spike (S) protein are thought to play a major role in controlling MERS-CoV infection and in mediating vaccine-induced protective immunity. In contrast, relatively little is known about the role of T cell responses and the antigenic targets of MERS-CoV that are recognized by CD8+ T cells. In this study, the highly conserved MERS-CoV nucleocapsid (N) protein served as a target immunogen to elicit MERS-CoV-specific cellular immune responses. Modified Vaccinia virus Ankara (MVA), a safety-tested strain of vaccinia virus for preclinical and clinical vaccine research, was used for generating MVA-MERS-N expressing recombinant N protein.">
    <entity charOffset="90-96" id="9dd88265053594d2736a884a8b972b6ae94218c5.c1.e0" ontology_id="HP_0012828" text="severe" type="phenotype"/>
    <entity charOffset="542-554" id="9dd88265053594d2736a884a8b972b6ae94218c5.c1.e1" ontology_id="GO_0019013" text="nucleocapsid" type="gene_function"/>
    <pair e1="9dd88265053594d2736a884a8b972b6ae94218c5.c1.e0" e2="9dd88265053594d2736a884a8b972b6ae94218c5.c1.e1" id="9dd88265053594d2736a884a8b972b6ae94218c5.c1.p0" relation="true"/>
  </chunk>
  <chunk id="9dd88265053594d2736a884a8b972b6ae94218c5.c2" text="Overlapping peptides spanning the whole MERS-CoV N polypeptide were used to identify major histocompatibility complex class I/II-restricted T cell responses in BALB/c mice immunized with MVA-MERS-N. We have identified a H2-d restricted decamer peptide epitope in the MERS-N protein with CD8+ T cell antigenicity. The identification of this epitope, and the availability of the MVA-MERS-N candidate vaccine, will help to evaluate MERS-N-specific immune responses and the potential immune correlates of vaccine-mediated protection in the appropriate murine models of MERS-CoV infection.">
    <entity charOffset="85-117" id="9dd88265053594d2736a884a8b972b6ae94218c5.c2.e0" ontology_id="GO_0046776" text="major histocompatibility complex" type="gene_function"/>
  </chunk>
  <chunk id="9dd88265053594d2736a884a8b972b6ae94218c5.c3" text="At present, there is still relatively little known about the pathogenesis of MERS-CoV. The highest incidence of severe disease is observed in elderly and immunocompromised individuals [11] . Those at general risk for infections are health care workers and people in close contact with dromedary camels [12, 13] . These groups are therefore considered relevant target populations for prophylactic vaccination against MERS-CoV infection and prevention of MERS. The World Health Organization (WHO) and the Coalition for Epidemic Preparedness Innovations (CEPI) have listed MERS as priority target for vaccine development [14] . However, so far, no candidate vaccines have proceeded beyond phase I/IIa clinical testing [15] . One of these candidate vaccines is based on Modified Vaccinia virus Ankara (MVA), a safety-tested and replication-deficient vaccinia virus serving as an advanced viral vector platform for the development of new vaccines against infectious diseases and cancer (for review see [16] ). In that context, we still know relatively little about the correlates of vaccine induced protection against MERS-CoV. It is well-known that virus-neutralizing antibodies directed against the spike glycoprotein (S protein) correlate with protective immunity against coronavirus infections in general [17] [18] [19] [20] . Since the S protein is present on the cell surface, S protein is considered as the major antigen to induce virus neutralizing antibodies and as a key immunogen for the development of MERS-CoV candidate vaccines [21] [22] [23] [24] [25] . However, based on current knowledge from the biology of Î²-coronaviruses, we hypothesize that also other viral proteins warrant consideration as immunogens and targets of virus-specific antibodies and T cells. Among those, the nucleocapsid protein (N protein) is produced at high levels in infected cells and has been proposed as useful candidate protein for clinical diagnosis [26] [27] [28] [29] [30] . The coronavirus N proteins have been associated with multiple functions in the virus life cycle including the regulation of viral RNA synthesis, the packaging of the viral RNA in helical nucleocapsids, and in virion assembly through interaction with the viral M protein [31] [32] [33] [34] . Furthermore, several reports suggest that the severe acute respiratory syndrome coronavirus (SARS-CoV) N protein functions as an immune evasion protein and an antagonist of the host interferon response [35] [36] [37] . Recently, the overexpression of MERS-CoV N in human A549 cells was found to be linked to an up-regulation of antiviral host gene expression including the synthesis of the inflammatory chemokine CXCL10 [38] . Despite this possible immune modulatory activity, SARS-CoV N-specific immune responses are reported to be long-lived and more broadly reactive when compared to SARS-CoV S-specific immunity [39] . Likewise, we were curious as to the suitability of the MERS-CoV N protein to serve as a vaccine antigen. The N protein is not present on the surface of MERS-CoV particles nor is it predicted to be expressed on the surface membrane of MVA infected cells. From this we hypothesized that the most relevant part of MERS-CoV N-specific immunity is based on CD8+ T cell responses relying on the processing and presentation of intracellular antigens. Currently, there is little information about MERS-CoV N-specific immune responses including the in vivo induction of N-specific cellular immunity.">
    <entity charOffset="61-73" id="9dd88265053594d2736a884a8b972b6ae94218c5.c3.e0" ontology_id="GO_0009405" text="pathogenesis" type="gene_function"/>
    <entity charOffset="112-118" id="9dd88265053594d2736a884a8b972b6ae94218c5.c3.e1" ontology_id="HP_0012828" text="severe" type="phenotype"/>
    <entity charOffset="974-980" id="9dd88265053594d2736a884a8b972b6ae94218c5.c3.e2" ontology_id="HP_0002664" text="cancer" type="phenotype"/>
    <entity charOffset="1790-1802" id="9dd88265053594d2736a884a8b972b6ae94218c5.c3.e3" ontology_id="GO_0019013" text="nucleocapsid" type="gene_function"/>
    <entity charOffset="2102-2111" id="9dd88265053594d2736a884a8b972b6ae94218c5.c3.e4" ontology_id="GO_0009058" text="synthesis" type="gene_function"/>
    <entity charOffset="2177-2183" id="9dd88265053594d2736a884a8b972b6ae94218c5.c3.e5" ontology_id="GO_0019012" text="virion" type="gene_function"/>
    <entity charOffset="2177-2192" id="9dd88265053594d2736a884a8b972b6ae94218c5.c3.e6" ontology_id="GO_0019068" text="virion assembly" type="gene_function"/>
    <entity charOffset="2306-2312" id="9dd88265053594d2736a884a8b972b6ae94218c5.c3.e7" ontology_id="HP_0012828" text="severe" type="phenotype"/>
    <entity charOffset="2313-2318" id="9dd88265053594d2736a884a8b972b6ae94218c5.c3.e8" ontology_id="HP_0011009" text="acute" type="phenotype"/>
    <entity charOffset="2389-2403" id="9dd88265053594d2736a884a8b972b6ae94218c5.c3.e9" ontology_id="GO_0042783" text="immune evasion" type="gene_function"/>
    <entity charOffset="2603-2618" id="9dd88265053594d2736a884a8b972b6ae94218c5.c3.e10" ontology_id="GO_0010467" text="gene expression" type="gene_function"/>
    <entity charOffset="2633-2642" id="9dd88265053594d2736a884a8b972b6ae94218c5.c3.e11" ontology_id="GO_0009058" text="synthesis" type="gene_function"/>
    <entity charOffset="3105-3113" id="9dd88265053594d2736a884a8b972b6ae94218c5.c3.e12" ontology_id="GO_0016020" text="membrane" type="gene_function"/>
    <entity charOffset="3303-3316" id="9dd88265053594d2736a884a8b972b6ae94218c5.c3.e13" ontology_id="GO_0005622" text="intracellular" type="gene_function"/>
    <pair e1="9dd88265053594d2736a884a8b972b6ae94218c5.c3.e0" e2="9dd88265053594d2736a884a8b972b6ae94218c5.c3.e1" id="9dd88265053594d2736a884a8b972b6ae94218c5.c3.p0" relation="true"/>
    <pair e1="9dd88265053594d2736a884a8b972b6ae94218c5.c3.e0" e2="9dd88265053594d2736a884a8b972b6ae94218c5.c3.e2" id="9dd88265053594d2736a884a8b972b6ae94218c5.c3.p1" relation="true"/>
    <pair e1="9dd88265053594d2736a884a8b972b6ae94218c5.c3.e0" e2="9dd88265053594d2736a884a8b972b6ae94218c5.c3.e7" id="9dd88265053594d2736a884a8b972b6ae94218c5.c3.p2" relation="true"/>
    <pair e1="9dd88265053594d2736a884a8b972b6ae94218c5.c3.e0" e2="9dd88265053594d2736a884a8b972b6ae94218c5.c3.e8" id="9dd88265053594d2736a884a8b972b6ae94218c5.c3.p3" relation="true"/>
    <pair e1="9dd88265053594d2736a884a8b972b6ae94218c5.c3.e1" e2="9dd88265053594d2736a884a8b972b6ae94218c5.c3.e3" id="9dd88265053594d2736a884a8b972b6ae94218c5.c3.p4" relation="true"/>
    <pair e1="9dd88265053594d2736a884a8b972b6ae94218c5.c3.e1" e2="9dd88265053594d2736a884a8b972b6ae94218c5.c3.e4" id="9dd88265053594d2736a884a8b972b6ae94218c5.c3.p5" relation="true"/>
    <pair e1="9dd88265053594d2736a884a8b972b6ae94218c5.c3.e1" e2="9dd88265053594d2736a884a8b972b6ae94218c5.c3.e5" id="9dd88265053594d2736a884a8b972b6ae94218c5.c3.p6" relation="true"/>
    <pair e1="9dd88265053594d2736a884a8b972b6ae94218c5.c3.e1" e2="9dd88265053594d2736a884a8b972b6ae94218c5.c3.e6" id="9dd88265053594d2736a884a8b972b6ae94218c5.c3.p7" relation="true"/>
    <pair e1="9dd88265053594d2736a884a8b972b6ae94218c5.c3.e1" e2="9dd88265053594d2736a884a8b972b6ae94218c5.c3.e9" id="9dd88265053594d2736a884a8b972b6ae94218c5.c3.p8" relation="true"/>
    <pair e1="9dd88265053594d2736a884a8b972b6ae94218c5.c3.e1" e2="9dd88265053594d2736a884a8b972b6ae94218c5.c3.e10" id="9dd88265053594d2736a884a8b972b6ae94218c5.c3.p9" relation="true"/>
    <pair e1="9dd88265053594d2736a884a8b972b6ae94218c5.c3.e1" e2="9dd88265053594d2736a884a8b972b6ae94218c5.c3.e11" id="9dd88265053594d2736a884a8b972b6ae94218c5.c3.p10" relation="true"/>
    <pair e1="9dd88265053594d2736a884a8b972b6ae94218c5.c3.e1" e2="9dd88265053594d2736a884a8b972b6ae94218c5.c3.e12" id="9dd88265053594d2736a884a8b972b6ae94218c5.c3.p11" relation="true"/>
    <pair e1="9dd88265053594d2736a884a8b972b6ae94218c5.c3.e1" e2="9dd88265053594d2736a884a8b972b6ae94218c5.c3.e13" id="9dd88265053594d2736a884a8b972b6ae94218c5.c3.p12" relation="true"/>
    <pair e1="9dd88265053594d2736a884a8b972b6ae94218c5.c3.e2" e2="9dd88265053594d2736a884a8b972b6ae94218c5.c3.e3" id="9dd88265053594d2736a884a8b972b6ae94218c5.c3.p13" relation="true"/>
    <pair e1="9dd88265053594d2736a884a8b972b6ae94218c5.c3.e2" e2="9dd88265053594d2736a884a8b972b6ae94218c5.c3.e4" id="9dd88265053594d2736a884a8b972b6ae94218c5.c3.p14" relation="true"/>
    <pair e1="9dd88265053594d2736a884a8b972b6ae94218c5.c3.e2" e2="9dd88265053594d2736a884a8b972b6ae94218c5.c3.e5" id="9dd88265053594d2736a884a8b972b6ae94218c5.c3.p15" relation="true"/>
    <pair e1="9dd88265053594d2736a884a8b972b6ae94218c5.c3.e2" e2="9dd88265053594d2736a884a8b972b6ae94218c5.c3.e6" id="9dd88265053594d2736a884a8b972b6ae94218c5.c3.p16" relation="true"/>
    <pair e1="9dd88265053594d2736a884a8b972b6ae94218c5.c3.e2" e2="9dd88265053594d2736a884a8b972b6ae94218c5.c3.e9" id="9dd88265053594d2736a884a8b972b6ae94218c5.c3.p17" relation="true"/>
    <pair e1="9dd88265053594d2736a884a8b972b6ae94218c5.c3.e2" e2="9dd88265053594d2736a884a8b972b6ae94218c5.c3.e10" id="9dd88265053594d2736a884a8b972b6ae94218c5.c3.p18" relation="true"/>
    <pair e1="9dd88265053594d2736a884a8b972b6ae94218c5.c3.e2" e2="9dd88265053594d2736a884a8b972b6ae94218c5.c3.e11" id="9dd88265053594d2736a884a8b972b6ae94218c5.c3.p19" relation="true"/>
    <pair e1="9dd88265053594d2736a884a8b972b6ae94218c5.c3.e2" e2="9dd88265053594d2736a884a8b972b6ae94218c5.c3.e12" id="9dd88265053594d2736a884a8b972b6ae94218c5.c3.p20" relation="true"/>
    <pair e1="9dd88265053594d2736a884a8b972b6ae94218c5.c3.e2" e2="9dd88265053594d2736a884a8b972b6ae94218c5.c3.e13" id="9dd88265053594d2736a884a8b972b6ae94218c5.c3.p21" relation="true"/>
    <pair e1="9dd88265053594d2736a884a8b972b6ae94218c5.c3.e3" e2="9dd88265053594d2736a884a8b972b6ae94218c5.c3.e7" id="9dd88265053594d2736a884a8b972b6ae94218c5.c3.p22" relation="true"/>
    <pair e1="9dd88265053594d2736a884a8b972b6ae94218c5.c3.e3" e2="9dd88265053594d2736a884a8b972b6ae94218c5.c3.e8" id="9dd88265053594d2736a884a8b972b6ae94218c5.c3.p23" relation="true"/>
    <pair e1="9dd88265053594d2736a884a8b972b6ae94218c5.c3.e4" e2="9dd88265053594d2736a884a8b972b6ae94218c5.c3.e7" id="9dd88265053594d2736a884a8b972b6ae94218c5.c3.p24" relation="true"/>
    <pair e1="9dd88265053594d2736a884a8b972b6ae94218c5.c3.e4" e2="9dd88265053594d2736a884a8b972b6ae94218c5.c3.e8" id="9dd88265053594d2736a884a8b972b6ae94218c5.c3.p25" relation="true"/>
    <pair e1="9dd88265053594d2736a884a8b972b6ae94218c5.c3.e5" e2="9dd88265053594d2736a884a8b972b6ae94218c5.c3.e7" id="9dd88265053594d2736a884a8b972b6ae94218c5.c3.p26" relation="true"/>
    <pair e1="9dd88265053594d2736a884a8b972b6ae94218c5.c3.e5" e2="9dd88265053594d2736a884a8b972b6ae94218c5.c3.e8" id="9dd88265053594d2736a884a8b972b6ae94218c5.c3.p27" relation="true"/>
    <pair e1="9dd88265053594d2736a884a8b972b6ae94218c5.c3.e6" e2="9dd88265053594d2736a884a8b972b6ae94218c5.c3.e7" id="9dd88265053594d2736a884a8b972b6ae94218c5.c3.p28" relation="true"/>
    <pair e1="9dd88265053594d2736a884a8b972b6ae94218c5.c3.e6" e2="9dd88265053594d2736a884a8b972b6ae94218c5.c3.e8" id="9dd88265053594d2736a884a8b972b6ae94218c5.c3.p29" relation="true"/>
    <pair e1="9dd88265053594d2736a884a8b972b6ae94218c5.c3.e7" e2="9dd88265053594d2736a884a8b972b6ae94218c5.c3.e9" id="9dd88265053594d2736a884a8b972b6ae94218c5.c3.p30" relation="true"/>
    <pair e1="9dd88265053594d2736a884a8b972b6ae94218c5.c3.e7" e2="9dd88265053594d2736a884a8b972b6ae94218c5.c3.e10" id="9dd88265053594d2736a884a8b972b6ae94218c5.c3.p31" relation="true"/>
    <pair e1="9dd88265053594d2736a884a8b972b6ae94218c5.c3.e7" e2="9dd88265053594d2736a884a8b972b6ae94218c5.c3.e11" id="9dd88265053594d2736a884a8b972b6ae94218c5.c3.p32" relation="true"/>
    <pair e1="9dd88265053594d2736a884a8b972b6ae94218c5.c3.e7" e2="9dd88265053594d2736a884a8b972b6ae94218c5.c3.e12" id="9dd88265053594d2736a884a8b972b6ae94218c5.c3.p33" relation="true"/>
    <pair e1="9dd88265053594d2736a884a8b972b6ae94218c5.c3.e7" e2="9dd88265053594d2736a884a8b972b6ae94218c5.c3.e13" id="9dd88265053594d2736a884a8b972b6ae94218c5.c3.p34" relation="true"/>
    <pair e1="9dd88265053594d2736a884a8b972b6ae94218c5.c3.e8" e2="9dd88265053594d2736a884a8b972b6ae94218c5.c3.e9" id="9dd88265053594d2736a884a8b972b6ae94218c5.c3.p35" relation="true"/>
    <pair e1="9dd88265053594d2736a884a8b972b6ae94218c5.c3.e8" e2="9dd88265053594d2736a884a8b972b6ae94218c5.c3.e10" id="9dd88265053594d2736a884a8b972b6ae94218c5.c3.p36" relation="true"/>
    <pair e1="9dd88265053594d2736a884a8b972b6ae94218c5.c3.e8" e2="9dd88265053594d2736a884a8b972b6ae94218c5.c3.e11" id="9dd88265053594d2736a884a8b972b6ae94218c5.c3.p37" relation="true"/>
    <pair e1="9dd88265053594d2736a884a8b972b6ae94218c5.c3.e8" e2="9dd88265053594d2736a884a8b972b6ae94218c5.c3.e12" id="9dd88265053594d2736a884a8b972b6ae94218c5.c3.p38" relation="true"/>
    <pair e1="9dd88265053594d2736a884a8b972b6ae94218c5.c3.e8" e2="9dd88265053594d2736a884a8b972b6ae94218c5.c3.e13" id="9dd88265053594d2736a884a8b972b6ae94218c5.c3.p39" relation="true"/>
  </chunk>
  <chunk id="9dd88265053594d2736a884a8b972b6ae94218c5.c4" text="In this study, we investigated the synthesis and delivery of the MERS-CoV N protein as a privileged antigen by a MVA vector virus. The recombinant MVA expressing a synthetic gene sequence of full-length MERS-CoV N (MVA-MERS-N) proved genetically stable and fully replication-competent in chicken embryo fibroblasts, an established cell substrate for MVA vaccine manufacturing. Upon in vitro infection, MVA-MERS-N produced high amounts of the heterologous protein that were detectable with MERS-CoV N-specific antibodies. Furthermore, MVA-MERS-N was tested as an experimental vaccine in BALB/c mice and elicited MERS-CoV N-specific interferon Î³ (IFN-Î³)-producing CD8+ T cells. Using peptide library covering the whole MERS-CoV N polypeptide, we identified new H2-d restricted peptide epitopes of MERS-CoV N in BALB/c mice. This data will be highly relevant for further assessment of N antigen-specific immune responses in the well-established MERS-CoV-BALB/c mouse immunization/challenge model [40] [41] [42] [43] [44] .">
    <entity charOffset="35-44" id="9dd88265053594d2736a884a8b972b6ae94218c5.c4.e0" ontology_id="GO_0009058" text="synthesis" type="gene_function"/>
    <entity charOffset="246-252" id="9dd88265053594d2736a884a8b972b6ae94218c5.c4.e1" ontology_id="HP_0031915" text="stable" type="phenotype"/>
    <pair e1="9dd88265053594d2736a884a8b972b6ae94218c5.c4.e0" e2="9dd88265053594d2736a884a8b972b6ae94218c5.c4.e1" id="9dd88265053594d2736a884a8b972b6ae94218c5.c4.p0" relation="true"/>
  </chunk>
</document>
